CLINICAL_TRIALS
trial_result
· 2019-07-09
Clinical Trial Update: Inhaled Nitric Oxide for Patients With MABSC [Phase 2]
Summary
Phase 2 trial update on inhaled nitric oxide for patients with Mycobacterium abscessus infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beyond Air Inc. | Conditions: Mycobacterium Abscessus Infection | Phase 2 | Status: COMPLETED